88 related articles for article (PubMed ID: 34616801)
1. Efficacy of arbidol in COVID-19 patients: A retrospective study.
Wei S; Xu S; Pan YH
World J Clin Cases; 2021 Sep; 9(25):7350-7357. PubMed ID: 34616801
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Early Combination Therapy With Lianhuaqingwen and Arbidol in Moderate and Severe COVID-19 Patients: A Retrospective Cohort Study.
Fang J; Li H; Du W; Yu P; Guan YY; Ma SY; Liu D; Chen W; Shi GC; Bian XL
Front Pharmacol; 2020; 11():560209. PubMed ID: 33071781
[TBL] [Abstract][Full Text] [Related]
3. High serum lactate dehydrogenase and dyspnea: Positive predictors of adverse outcome in critical COVID-19 patients in Yichang.
Lv XT; Zhu YP; Cheng AG; Jin YX; Ding HB; Wang CY; Zhang SY; Chen GP; Chen QQ; Liu QC
World J Clin Cases; 2020 Nov; 8(22):5535-5546. PubMed ID: 33344544
[TBL] [Abstract][Full Text] [Related]
4. A trial of arbidol hydrochloride in adults with COVID-19.
Zhao J; Zhang J; Jin Y; Tang Z; Hu K; Sun H; Shi M; Yang Q; Gu P; Guo H; Li Q; Zhang H; Li C; Yang M; Xiong N; Dong X; Xu J; Lin F; Wang T; Yang C; Huang B; Zhang J; Chen S; He Q; Zhou M; Qu J
Chin Med J (Engl); 2022 Jul; 135(13):1531-8. PubMed ID: 35830201
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of Arbidol for COVID-19 Prevention in Health Professionals.
Yang C; Ke C; Yue D; Li W; Hu Z; Liu W; Hu S; Wang S; Liu J
Front Public Health; 2020; 8():249. PubMed ID: 32574310
[No Abstract] [Full Text] [Related]
6. Comparison of the antiviral effect of Arbidol and Chloroquine in treating COVID-19.
Li M; Yu T; Zhu J; Wang Y; Yang Y; Zhao K; Yi Y; He J; Li C; He J
Ann Palliat Med; 2021 Mar; 10(3):3307-3312. PubMed ID: 33849115
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effect of Arbidol in the management of COVID-19 infection.
Jie X; Hongmei Y; Ping F; Kuikui Z; Bohan Y; Rui M
Aging (Albany NY); 2021 Apr; 13(7):9253-9264. PubMed ID: 33811756
[TBL] [Abstract][Full Text] [Related]
8. Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study.
Lian N; Xie H; Lin S; Huang J; Zhao J; Lin Q
Clin Microbiol Infect; 2020 Jul; 26(7):917-921. PubMed ID: 32344167
[TBL] [Abstract][Full Text] [Related]
9. Methylprednisolone accelerate chest computed tomography absorption in COVID-19: A three-centered retrospective case control study from China.
Lin L; Xue D; Chen JH; Wei QY; Huang ZH
World J Clin Cases; 2022 Jan; 10(2):426-436. PubMed ID: 35097067
[TBL] [Abstract][Full Text] [Related]
10. Favipiravir Versus Arbidol for Clinical Recovery Rate in Moderate and Severe Adult COVID-19 Patients: A Prospective, Multicenter, Open-Label, Randomized Controlled Clinical Trial.
Chen C; Zhang Y; Huang J; Yin P; Cheng Z; Wu J; Chen S; Zhang Y; Chen B; Lu M; Luo Y; Ju L; Zhang J; Wang X
Front Pharmacol; 2021; 12():683296. PubMed ID: 34539392
[No Abstract] [Full Text] [Related]
11. Real-world experience of arbidol for Omicron variant of SARS-CoV-2.
Zhao J; Li Y; Chen R; Xu Y; Yang Q; Zhang H; Yin Z; Gu W; Hu J; Chen L; Li J; Ning G; Cheng Q; Zhou M; Qu J
J Thorac Dis; 2023 Feb; 15(2):452-461. PubMed ID: 36910077
[TBL] [Abstract][Full Text] [Related]
12. Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study.
Deng L; Li C; Zeng Q; Liu X; Li X; Zhang H; Hong Z; Xia J
J Infect; 2020 Jul; 81(1):e1-e5. PubMed ID: 32171872
[TBL] [Abstract][Full Text] [Related]
13. Corticosteroid, oseltamivir and delayed admission are independent risk factors for prolonged viral shedding in patients with Coronavirus Disease 2019.
Hu F; Yin G; Chen Y; Song J; Ye M; Liu J; Chen C; Song Y; Tang X; Zhang Y
Clin Respir J; 2020 Nov; 14(11):1067-1075. PubMed ID: 32750201
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China.
Zeng Z; Yu H; Chen H; Qi W; Chen L; Chen G; Yan W; Chen T; Ning Q; Han M; Wu D
Crit Care; 2020 Aug; 24(1):525. PubMed ID: 32854750
[TBL] [Abstract][Full Text] [Related]
15. Potential of Arbidol for Post-exposure Prophylaxis of COVID-19 Transmission: A Preliminary Report of a Retrospective Cohort Study.
Zhang JN; Wang WJ; Peng B; Peng W; Zhang YS; Wang YL; Wan Y; Chang J; Mao L; Miao XP; Li YN; Zhou YF; Hu B
Curr Med Sci; 2020 Jun; 40(3):480-485. PubMed ID: 32474860
[TBL] [Abstract][Full Text] [Related]
16. Comparison of acute pneumonia caused by SARS-COV-2 and other respiratory viruses in children: a retrospective multi-center cohort study during COVID-19 outbreak.
Ren GL; Wang XF; Xu J; Li J; Meng Q; Xie GQ; Huang B; Zhu WC; Lin J; Tang CH; Ye S; Li Z; Zhu J; Tang Z; Ma MX; Xie C; Wu YW; Liu CX; Yang F; Zhou YZ; Zheng Y; Lan SL; Chen JF; Ye F; He Y; Wu BQ; Chen L; Fu SM; Zheng CZ; Shi Y
Mil Med Res; 2021 Feb; 8(1):13. PubMed ID: 33593415
[TBL] [Abstract][Full Text] [Related]
17. Antiviral drugs arbidol and interferon alpha-1b contribute to reducing the severity of COVID-19 patients: a retrospective cohort study.
Yin P; Meng J; Chen J; Gao J; Wang D; Liu S; Guo Q; Zhu M; Zhang G; Liu Y; Li Y; Zhang G
Virol J; 2021 Jul; 18(1):142. PubMed ID: 34238341
[TBL] [Abstract][Full Text] [Related]
18. Comparison and clinical characteristics of COVID-19 between January and February 2020 in Wuhan, China.
Yang R; Wei J; Hu W; Xiong J; Liu M; Hu K
Ann Palliat Med; 2021 Apr; 10(4):4201-4213. PubMed ID: 33832296
[TBL] [Abstract][Full Text] [Related]
19. Arbidol combined with the Chinese medicine Lianhuaqingwen capsule versus arbidol alone in the treatment of COVID-19.
Liu L; Shi F; Tu P; Chen C; Zhang M; Li X; Li C
Medicine (Baltimore); 2021 Jan; 100(4):e24475. PubMed ID: 33530261
[TBL] [Abstract][Full Text] [Related]
20. Clinical Characteristics and Outcomes of Childbearing-Age Women With COVID-19 in Wuhan: Retrospective, Single-Center Study.
Wei L; Gao X; Chen S; Zeng W; Wu J; Lin X; Zhang H; Mwamaka Sharifu L; Chen L; Feng L; Wang S
J Med Internet Res; 2020 Aug; 22(8):e19642. PubMed ID: 32750000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
